These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1716605)

  • 61. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
    Aguejouf O; Doutremepuich F; Doutremepuich C
    Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus.
    Min SK; Kwon OC; Lee S; Park KH; Kim JK
    Phytother Res; 2012 May; 26(5):752-7. PubMed ID: 22084059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
    Visconte C; Sainte-Marie M; Lorrain J; Millet L; O'Connor SE; Schaeffer P; Herbert JM
    J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antithrombotic potential of GW813893: a novel, orally active, active-site directed factor Xa inhibitor.
    Abboud MA; Needle SJ; Burns-Kurtis CL; Valocik RE; Koster PF; Amour AJ; Chan C; Brown D; Chaudry L; Zhou P; Patikis A; Patel C; Pateman AJ; Young RJ; Watson NS; Toomey JR
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):66-71. PubMed ID: 18645410
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of experimental coronary thrombosis by hirudin.
    Bucha E; Nowak G; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):52-8. PubMed ID: 2459032
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Antithrombotic effects of molsidomine, isosorbide dinitrate and verapamil in a laser-induced thrombosis model].
    Krupiński K; Breddin H; Bielawiec M
    Kardiol Pol; 1993 Aug; 39(8):100-4. PubMed ID: 8231003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
    Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report.
    Whelen S; Carr ME
    Angiology; 2001 Oct; 52(10):711-5. PubMed ID: 11666136
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S; Johansson K; Kjaer M; Elg M
    Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
    Weichert W; Pauliks V; Breddin HK
    Haemostasis; 1983; 13(1):61-71. PubMed ID: 6132858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-lasting antithrombotic effects of a single dose of human recombinant, active site-blocked factor VII: insights into possible mechanism(s) of action.
    Cirillo P; Golino P; Ragni M; D'andrea D; Calabró P; Corcione N; Vigorito F; Ravera M; Chiariello M
    J Thromb Haemost; 2003 May; 1(5):992-8. PubMed ID: 12871367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recombinant soluble human thrombomodulin: a randomized, blinded assessment of prevention of venous thrombosis and effects on hemostatic parameters in a rat model.
    Solis MM; Vitti M; Cook J; Young D; Glaser C; Light D; Morser J; Wydro R; Yu S; Fink L
    Thromb Res; 1994 Mar; 73(6):385-94. PubMed ID: 8073391
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A preparation to study simultaneous arterial and venous thrombus formation in rabbits.
    Baum PK; Martin D; Abendschein D
    J Invest Surg; 2001; 14(3):153-60. PubMed ID: 11453180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of recombinant hirudin on arterial thrombosis.
    Wallis RB
    Adv Exp Med Biol; 1993; 340():237-41. PubMed ID: 8154340
    [No Abstract]   [Full Text] [Related]  

  • 75. Low doses of endotoxin potentiate venous thrombosis in the rabbit.
    Bernat A; Sainte-Marie M; Roque C; Ingelaere V; Maffrand JP; Herbert JM
    Haemostasis; 1994; 24(4):209-18. PubMed ID: 7988950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of low-molecular-weight heparins on laser-induced thrombus formation in rat mesenteric vessels.
    Weichert W; Breddin HK
    Haemostasis; 1988; 18 Suppl 3():55-63. PubMed ID: 2840375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A highly reproducible model of arterial thrombosis in rats.
    Guarini S
    J Pharmacol Toxicol Methods; 1996 Apr; 35(2):101-5. PubMed ID: 8729436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-vivo antithrombotic potency of placenta protein 4 (annexin V).
    Römisch J; Seiffge D; Reiner G; Pâques EP; Heimburger N
    Thromb Res; 1991 Jan; 61(2):93-104. PubMed ID: 1826976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The antithrombotic effect of human activated protein C on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
    Yamashita T; Matsuoka A; Funatsu A; Yamamoto J
    Thromb Res; 1994 Jul; 75(1):33-40. PubMed ID: 8073406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Engineering a "three-in-one" hirudin prodrug to reduce bleeding risk: A proof-of-concept study.
    Zhu Y; Han HH; Zhai L; Yan Y; Liu X; Wang Y; Lei L; Wang JC
    J Control Release; 2021 Oct; 338():462-471. PubMed ID: 34481024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.